Fron­tier Med­i­cines rais­es $80M, en­ters clin­ic and eyes po­ten­tial IPO in Q4 or ear­ly 2025

Fron­tier Med­i­cines, a bi­coastal biotech cre­at­ing co­va­lent small mol­e­cules, has se­cured $80 mil­lion in Se­ries C funds and dosed the first pa­tient in its ini­tial …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER